India's healthcare sector offers international hospital groups opportunities to expand into new patient markets, specialist treatment, diagnostics and healthcare services. However, a Healthcare Business Acquisition requires careful legal and regulatory assessment before a foreign investor purchases shares, acquires hospital assets or enters a joint venture with an Indian healthcare provider.

Foreign investment is permitted in many healthcare activities, but the applicable conditions depend on the target's business, ownership structure and operations. A hospital acquisition may also involve state level clinical establishment requirements, biomedical waste management, medical professional standards, patient records, land use and existing contractual obligations.A successful transaction therefore requires more than financial due diligence. The buyer must establish whether the investment is permitted, identify approvals required for the transaction and confirm the target can continue operating lawfully after completion.

Can a Foreign Hospital Group Invest in India's Healthcare Sector?

India generally permits up to 100% foreign direct investment under the automatic route in hospitals and other eligible healthcare activities, subject to the applicable foreign investment policy and sector specific rules. The automatic route generally means prior government approval for the FDI itself is not required.However, the term healthcare covers a wide range of activities. Operating a hospital, providing diagnostic services, manufacturing medical devices, running a pharmacy and developing healthcare software may involve different regulatory frameworks. A buyer should identify the target's actual activities rather than treating every healthcare business as subject to identical conditions.

The proposed transaction structure also matters. Acquiring shares in an existing Indian company differs from purchasing selected hospital assets, establishing a joint venture or investing in a new operating entity. Each structure has distinct consequences for licences, contracts, liabilities and business continuity.Investors should review the current policy published by the Department for Promotion of Industry and Internal Trade, together with applicable foreign exchange regulations. They should also examine whether the transaction involves any activity subject to separate restrictions or approval requirements.

Choose the Right Acquisition Structure

A foreign hospital group may acquire an Indian healthcare business through a share purchase, an asset purchase, a merger or a joint venture. The appropriate structure depends on the target's legal status, existing liabilities, commercial arrangements and the buyer's long term plans.Under a share purchase, the buyer acquires shares in the company operating the healthcare business. The company generally continues to own its assets and remain party to its existing contracts. However, the buyer also inherits the economic exposure associated with the company's existing and potential liabilities.

An asset purchase allows the buyer to select specified assets and business operations, subject to the relevant transfer rules. Yet licences, employment arrangements, leases, patient contracts and other permissions may not automatically transfer with the assets. The buyer must establish which consents or fresh registrations are required.A joint venture can help an international hospital group work with an established Indian partner. It may provide local operational knowledge, clinical expertise and access to existing infrastructure. The parties should define governance rights, funding commitments, clinical responsibilities, reserved matters and exit arrangements before signing.The structure should be selected only after reviewing the target's legal position and the practical requirements for continuing healthcare services.

Review Foreign Investment and Transaction Reporting

Even where foreign investment is permitted under the automatic route, the acquisition must comply with applicable foreign exchange laws and reporting requirements.The buyer should confirm the permitted investment instrument, pricing rules, payment arrangements and reporting obligations. Share acquisitions involving residents and non residents may trigger specific requirements under the Foreign Exchange Management Act and the Foreign Exchange Management (Non Debt Instruments) Rules.

The parties should also verify the seller's ownership, the target company's capital structure and any existing restrictions on share transfers. Shareholder agreements, investor rights, pledges, options and convertible instruments can affect the transaction's implementation.If the acquisition involves an overseas parent, an Indian subsidiary and other group companies, the funding route should be documented carefully. Equity investment, debt funding, management charges and royalty arrangements may receive different regulatory and tax treatment.Investors exploring NRI investment opportunities in healthcare should also distinguish between the rules applicable to non resident Indians and those applicable to foreign corporate investors. Nationality, residence status, investment route and the nature of the investor can affect the applicable framework.

Conduct Healthcare Licensing and Operational Due Diligence

Healthcare businesses operate under multiple regulatory requirements. Before acquiring a hospital or clinic, the buyer should prepare a licence and registration inventory covering each facility and its activities.

Depending on the location and services provided, this may include registration under applicable clinical establishment legislation or state nursing home laws, local trade permissions, fire safety approvals, building permissions and authorisations for specific medical services.The buyer should also examine whether the target's facilities comply with applicable requirements for laboratories, blood banks, imaging services, pharmacies and other specialised units. The exact approvals depend on the services offered and the relevant central and state rules.

A valid registration should not be assumed to cover every service delivered by the facility. Investors should compare the approved activities with the actual operations, including any recently introduced departments or expanded treatment services.The transaction documents should identify permissions requiring renewal, transfer, amendment or fresh application. Where a regulatory approval cannot be transferred automatically, completion planning should address the steps needed to maintain lawful operations.

Assess Clinical Governance and Medical Professional Compliance

The quality of clinical governance is a major acquisition risk. The buyer should review medical staff credentials, professional registrations, clinical protocols, patient consent processes, infection control procedures and systems for reporting adverse events.The status of doctors and other regulated professionals should be verified through the relevant professional registration framework. The buyer should also examine employment and consultancy arrangements, including restrictive covenants, termination rights, fee structures and responsibility for professional indemnity cover.

Past medical negligence claims, patient complaints, disciplinary proceedings and clinical incidents may reveal weaknesses in governance. The review should consider both disclosed claims and recurring patterns in complaints or patient outcomes.Hospital policies should also address informed consent, record keeping, referrals, emergency care and the handling of vulnerable patients. Weak processes can create legal exposure and damage the reputation of the acquired business.A foreign hospital group should avoid assuming its international clinical protocols can simply replace Indian legal requirements. Local law, professional standards and the services provided at each facility must guide the compliance framework.

Review Patient Data and Digital Health Systems

Healthcare acquisitions frequently involve sensitive patient information, electronic medical records, diagnostic images, billing data and digital appointment systems. The buyer should determine how the target collects, stores, uses and shares this information.The review should cover access controls, cybersecurity safeguards, vendor contracts, data retention practices, consent procedures and incident response arrangements. Particular attention is needed where patient information is hosted by third party technology providers or transferred between group companies.

India's Digital Personal Data Protection framework and any applicable rules, commencement notifications and other relevant legal requirements should be assessed as at the transaction date. Other laws and sector specific obligations may also affect medical records and confidentiality.The buyer should not assume it can freely transfer all patient data to an overseas parent following completion. The lawful basis for processing, patient information duties, security controls and any applicable restrictions need to be evaluated.Data protection obligations should also be reflected in the acquisition agreement. The parties should define responsibility for historic breaches, regulatory inquiries, remediation costs and cooperation during the transition.

Examine Biomedical Waste and Environmental Compliance

Hospitals generate biomedical waste, wastewater and other materials requiring controlled handling. Environmental and public health compliance should therefore form a core part of acquisition due diligence.The buyer should verify the target's authorisations under the Biomedical Waste Management Rules, 2016, where applicable, along with its arrangements for waste segregation, storage, treatment and disposal. Records should demonstrate compliance with the relevant State Pollution Control Board or Pollution Control Committee requirements.

The review should also cover wastewater treatment, emissions from backup generators, chemical storage, radiation safety where relevant and environmental permissions for the premises. Any outstanding notices, inspection findings or remediation directions should be examined.A facility may appear operationally successful while carrying unresolved compliance risks. Investors should assess whether additional equipment, changes to waste handling or upgrades to the premises will be required after completion.The purchase price and transaction timetable should reflect the cost and time needed to address material deficiencies.

Check Competition Law and Change of Control Requirements

Large acquisitions may require review under India's competition law framework. Whether a filing is necessary depends on the transaction structure, applicable thresholds, exemptions and the rules in force at the time.The buyer should assess the combined market position of the hospital group and target, particularly where both operate in the same city or specialist treatment market. Relevant factors may include hospital beds, specialist services, diagnostic capacity, patient catchment areas and relationships with insurers or corporate healthcare purchasers.

The Competition Commission of India administers India's competition framework. Investors should confirm whether the transaction qualifies as a combination requiring notification and whether any applicable exemption is available.The acquisition agreement should address responsibility for regulatory filings, cooperation obligations, long stop dates and the consequences of a delayed or conditional approval.Other consents may also be required from lenders, landlords, joint venture partners or contractual counterparties. These should be identified early to avoid disruption at completion.

Review Employees, Property and Commercial Contracts

A hospital acquisition may involve a large workforce of doctors, nurses, technicians, administrative staff and outsourced service providers. The buyer should examine employment terms, outstanding wages, statutory contributions, leave liabilities, workplace disputes and contractual arrangements with staffing agencies.The review should identify any changes in employment terms or transfers requiring legal steps. The consequences may differ between a share acquisition and an asset transfer.Property due diligence is equally important. The buyer should verify title or lease rights, permitted use, construction approvals, access rights, encumbrances and restrictions on transfer. Hospital premises may require significant investment in specialised infrastructure, so defects in ownership or building permissions can materially affect value.

Commercial agreements with insurers, third party administrators, suppliers, laboratories, medical equipment providers and pharmaceutical distributors should also be reviewed. Change of control clauses, termination rights and exclusivity provisions may affect the target's revenue and operating continuity.For a buyer planning to establish a company for the acquisition, the proposed entity's ownership, governance, funding and regulatory responsibilities should be aligned with the transaction structure and intended healthcare activities.

Structure the Deal to Manage Identified Risks

Due diligence should inform the acquisition agreement rather than remain a separate exercise. The buyer should identify which risks can be resolved before completion, which require a price adjustment and which can be addressed through contractual protections.Representations and warranties should cover key matters such as ownership, licences, compliance, litigation, employees, taxes, patient data and material contracts. Indemnities may be appropriate for identified historic liabilities, subject to negotiation and enforceability.

Completion conditions should specify any essential regulatory approvals, third party consents or corrective actions. The agreement should also allocate responsibility for regulatory cooperation and the consequences if a necessary approval is delayed or refused.Where material deficiencies cannot be resolved before closing, the buyer should assess whether they justify a revised price, escrow arrangement, specific indemnity or decision not to proceed. The chosen protections should reflect the nature and financial significance of each risk.

Conclusion

A foreign hospital group can often acquire an Indian healthcare business, but the transaction requires a detailed review of ownership rules, healthcare licences, clinical governance, patient data, environmental obligations and commercial liabilities.The strongest acquisition strategy combines legal due diligence with a realistic assessment of operational continuity and post completion compliance. By identifying risks before signing and allocating responsibility clearly in the transaction documents, the buyer can make a better informed investment decision and build a more sustainable presence in India's healthcare sector.

Frequently Asked Questions

Can a foreign company own 100% of an Indian hospital?

Generally, up to 100% foreign direct investment is permitted under the automatic route in eligible hospital activities, subject to applicable law and the specific nature of the business.

Does buying a hospital automatically transfer its licences?

Not always. The position depends on the type of transaction, the relevant licence and the governing law. Some approvals may require amendment, consent or a fresh application.

Is government approval required for every foreign healthcare acquisition?

No. The FDI route and any separate regulatory requirements must be assessed individually. Competition law, healthcare licensing and other approvals may apply even where prior government approval for the foreign investment itself is not required.

What is the most important due diligence area in a hospital acquisition?

There is no single answer for every transaction. Licensing, clinical governance, patient data, environmental compliance, property rights and historic liabilities can all be material. The review should reflect the target's facilities, services and risk profile.

Can a foreign hospital group transfer Indian patient data to its overseas parent?

Not automatically. The proposed transfer and processing must comply with applicable Indian data protection and other relevant legal requirements.

This update was released on 09 Dec 2026.

The views expressed in this update are personal and should not be construed as any legal advice. Please contact us directly on +91 22 40565252 or contact@mhcolaw.com for any assistance.

Legal Update Team
MANSUKHLAL HIRALAL & COMPANY
Advocates, Solicitors and Notaries
T: +91 22 40565252
Mumbai Office: Surya Mahal, 2nd Floor, 5, Burjorji Bharucha Marg, Fort, Mumbai-400 023, India
Delhi Office: Block C-9, Lower Ground Floor, Jangpura Extension, New Delhi - 110 014, India
www.mhcolaw.com

"Noted lawyer in the Real Estate practitioner from India" - Chambers & Partners

Please consider the environment before printing this email

The information contained in this communication is intended solely for the use of the individual or entity to whom it is addressed and others authorized to receive it. This communication may contain confidential or legally privileged information. If you are not the intended recipient, any disclosure, copying, distribution or action taken relying on the contents is prohibited and may be unlawful. If you have received this communication in error, or if you or your employer does not consent to email messages of this kind, please notify the sender immediately by responding to this email and then delete it from your system. No liability is accepted for any harm that may be caused to your systems or data by this message.